[1] SAMPSONAS F,ARCHONTIDOU MA,SALLA E,et al.Genetic alterations of glutathione S-transferases in asthma:do they modulate lung growth and response to environmental stimuli?[J].Allergy Asthma Proc,2007,28(3):282.
[2] 戴青原,郭涛.氧化应激与糖尿病及动脉粥样硬化研究进展[J].心血管病学进展,2013,34(5):664.
[3] NOLD MF,NOLD-PETRY CA,ZEEPP JA,et al.IL-37 is a fundamental inhibitor of innate immunity[J].Nat Immunol,2010,11(11):1014.
[4] BORASCHI D,LUCCHESI D,HAINZL S,et al.IL-37:a new anti-inflammatory cytokine of the IL-1 family[J].Eur Cytokine Netw,2011,22(3):127.
[5] ZHAO JJ,PAN QZ,PAN K,et al.Interleukin-37 mediates the antitumor activity in hepatocellular carcinoma:role for CD57+ NK cells[J].Sci Rep,2014,4(5177):1.
[6] WAN ZY,SUN Z,SONG F,et al.Downregulated interleukin 37 expression associated with aggravation of intervertebral disc degeneration[J].Int J Clin Exp Pathol,2014,7(2):656.
[7] WU BW,ZENG QT,MENG K,et al.The potential role of IL-37 in atherosclerosis[J].Pharmazie,2013,68(11):857.
[8] GOODARZI MT,NAVIDI AA,REZAEI M,et al.Oxidative damage to DNA and lipids:correlation with protein glycation in patients with type 1 diabetes[J].J Clin Lab Anal,2010,24(2):72.
[9] COHEN RA,TONG X.Vascular oxidative stress:the common link in hyper-tensive and diabetic vascular disease[J].J Cardiovase Pharmacol,2010,55(4):308.